Hc. Lee et al., MECHANISM OF ALPHA-2-ADRENERGIC MODULATION OF CANINE CARDIAC PURKINJEACTION-POTENTIAL, The Journal of pharmacology and experimental therapeutics, 278(2), 1996, pp. 597-606
We reported recently that stimulation of postjunctional alpha-2 adrene
rgic receptors prolongs the action potential durations (APD) of isolat
ed canine Purkinje fibers. With standard microelectrode techniques, we
examined the ionic mechanism through which alpha-2 adrenergic stimula
tion prolonged Purkinje APD, by measuring the effects of inhibitors of
the various plateau currents on the alpha-2-mediated prolongation of
APD. The alpha-2-specific agonist UK 14,304 (0.1 mu M) prolonged the P
urkinje APD at 50% repolarization and the APD at 90% repolarization, a
nd these effects were inhibited by yohimbine (0.1 mu M). The Purkinje
APD at 50% repolarization and the APD at 90% repolarization were prolo
nged significantly with the transient outward potassium current inhibi
tor 4-aminopyridine (1 mM), the rapid component of delayed rectifier p
otassium current inhibitor d-sotalol (10 mu m), the slow component of
delayed rectifier potassium current inhibitor indapamide (0.1 mu M) an
d the chloride current inhibitor mefenamic acid (10 nM) and were short
ened significantly with the calcium current inhibitor nifedipine (0.3
mu M). Prolongation of Purkinje APD at 50% repolarization and APD at 9
0% repolarization by UK 14,304 remained intact in the presence of d-so
talol, indapamide, mefenamic acid and nifedipine. All of these UK 14,3
04 effects were significantly reversed by yohimbine. Only in the prese
nce of 4-aminopyridine did UK 14,304 fail to prolong Purkinje APD. The
phase 1 magnitudes of Purkinje action potentials were also significan
tly inhibited by UK 14,304. This effect was completely abolished only
in the presence of 4-aminopyridine. These results suggest that inhibit
ion of the 4-aminopyridine-sensitive transient outward potassium curre
nt is the major ionic mechanism by which alpha-2 adrenergic stimulatio
n prolongs Purkinje APD.